Out-licensing: Immune Related Disorders

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing
Browse

Licensing opportunities

Displaying 1..10 of 116 - per page Next page
Order by

Coupling drug substances with hydroxyethyl starch (HES) derivatives to improve pharmacokinetics and pharmacodynamics. More

Micro Fine, Dry Powder Pulmonary Drug Delivery Technology Suite

Researchers at the University of Western Ontario have developed a Pulmonary Drug Delivery Technology Suite comprised of two innovative inventions for the precision measurement and dispensing of micro fine, dry powders. More

Cripto-1 Represents a Biomarker for Chronic Inflammatory Diseases

Cripto-1 expression increases the expression of TNF-alpha in CD4+ T cells in tissues affected by chronic inflammatory disease. More

A NEW AEROSOL TREATMENT FOR ASTHMA USING A NON-STEROIDAL COMPLEX WHICH PREVENTS BRONCHIAL REMODELLING

Aerosolized pharmaceutical composition with low potential toxicity, significantly reducing airway inflammation and remodelling More

Desalazine Sodium: Anti-inflammatory agent, Phase II, indicated for the topical treatment of ulcerative colitis.

The molecule is an azo derivative of an active molecule (UR-12715, anti-TNFalpha and PAF antagonist ) and 5-aminosalicylic acid (5-ASA), the gold standard treatment for mild to moderate ulcerative colitis. More

Protein (Biomolecule) Transduction Domain (PTD)

Rheumatoid arthritis More

Enhanced T-cell Activation by Costimulation: An Effective Immunotherapy for Cancer and Infectious Diseases

The present technology describes recombinant poxvirus vectors encoding at least three or more costimulatory molecules and TAAs. More

TNF-alpha Converting Enzyme Inhibitory Agents and Stimulatory Agents

This TACE inhibitory protein could be used as a new therapeutic agent against chronic inflammatory diseases that are mediated by TNF-alpha. More

ImmLab's primary product: A Therapeutic Staphylococcal Lysate (SL) as described in our patent 6,929,798 and 7,329,409 granted by the U.S. Patent and Trademark Office

SL is prepared by lysis of S. aureus culture with a polyvalent bacteriophage. More

Chitosan as a Universal Vaccine Adjuvant, Antigen Depot and Cytokine Depot

This technology is the first to show that subcutaneous administrations of chitosan and an appropriate antigen, with no other component, can be used for enhancing immune responses. More

Displaying 1..10 of 116 - per page Next page
Order by

Your selection

Therapeutic target: Immune related disorders del

Browse By

Industry sector: Animal health; Biotechnology; Diagnostic; Drug delivery; Drug discovery; Medical device; Pharmaceutical; Research tools
Therapeutic target: Adoptive immunotherapy; Amyloidosis; Autoimmune disease (non-specific); Chronic fatigue syndrome; Chronic granulomatous disease; Chronic immunosuppression; Gout; Graft versus host disease; HIV/AIDS; Immune disorder (non-specific); Immune thrombocytopenic purpura; Immunomodulation; Immunostimulation; Immunosuppression; Lupus erythematosis; Myalgic encephalomyelitis; Myasthenia gravis; Neoplastic disease; Organ transplant rejection; Rheumatoid arthritis; Servere combined immunodeficency; Sjogren's syndrome; Systemic sclerosis; Transplant rejection; Xenotransplantation
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us